Lv11
25 积分 2022-01-12 加入
The treatment of advanced melanoma: Current approaches and new challenges
1小时前
已完结
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
6天前
已完结
Prediction of Creatinine Clearance from Serum Creatinine
2个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
2个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
2个月前
已完结
Prediction of Creatinine Clearance from Serum Creatinine
2个月前
已完结
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
3个月前
已完结
The Proposed 9th Edition TNM Classification of Lung Cancer
3个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
